Rebecca Mikel Tinsley, | |
19 Olson Rd, Aladdin, WY 82710-9707 | |
(307) 290-2606 | |
Not Available |
Full Name | Rebecca Mikel Tinsley |
---|---|
Gender | Female |
Speciality | Registered Nurse - Psychiatric/mental Health |
Location | 19 Olson Rd, Aladdin, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194447474 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WP0808X | Registered Nurse - Psychiatric/mental Health | 31210 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Mikel Tinsley, 19 Olson Rd, Aladdin, WY 82710-9707 Ph: (307) 290-2606 | Rebecca Mikel Tinsley, 19 Olson Rd, Aladdin, WY 82710-9707 Ph: (307) 290-2606 |
News Archive
Researchers with the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Department of Chemistry have won an $805,000 grant from the U.S. Department of Defense Breast Cancer Research Program to study whether dead cancer cells left over after treatment encourage cancer's spread to other parts of the body.
UNISON will step up its campaign in support of the NHS, while opposing privatisation and the growth of the market, its national conference decided in Brighton this afternoon.
The Coalition for Pulmonary Fibrosis and the American Thoracic Society, the world's leading professional organization for pulmonary, critical care and sleep physicians, today announced that the CPF will again partner with the ATS to fund Pulmonary Fibrosis (PF) research.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
› Verified 2 days ago